You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Improved efficacy against malignant brain tumors with EGFRwt/EGFRvIII targeting immunotoxin and checkpoint inhibitor combinations

Article metrics

Article menu

Download PDFPDF

XML
Research Article
Improved efficacy against malignant brain tumors with EGFRwt/EGFRvIII targeting immunotoxin and checkpoint inhibitor combinations

 

Online download statistics by month:

Online download statistics by month: December 2019 to June 2025

AbstractFullPdf
Dec 2019330
Jan 202016162
Feb 202020203
Mar 202023239
Apr 2020272748
May 2020262617
Jun 2020353515
Jul 2020323243
Aug 2020161613
Sep 2020323219
Oct 2020414213
Nov 2020212114
Dec 2020252515
Jan 2021333315
Feb 2021212116
Mar 2021282825
Apr 2021292917
May 2021212111
Jun 2021252516
Jul 2021262618
Aug 2021353524
Sep 2021222216
Oct 2021252528
Nov 2021373726
Dec 2021313117
Jan 2022222312
Feb 2022252616
Mar 2022232519
Apr 2022252820
May 2022182027
Jun 2022232311
Jul 2022222315
Aug 2022212210
Sep 2022262721
Oct 2022182122
Nov 2022282818
Dec 202239399
Jan 2023434312
Feb 2023303124
Mar 2023343428
Apr 2023101219
May 2023323333
Jun 2023262621
Jul 2023283017
Aug 2023202230
Sep 2023333333
Oct 2023303014
Nov 2023343418
Dec 2023363720
Jan 2024485012
Feb 2024575714
Mar 2024353520
Apr 202414314214
May 2024333416
Jun 2024434320
Jul 2024303113
Aug 2024353511
Sep 2024161613
Oct 2024242426
Nov 2024293017
Dec 2024576014
Jan 2025393931
Feb 2025242417
Mar 2025343444
Apr 2025323218
May 2025262536
Jun 202510107
Total201120421252